Torrent Pharmaceuticals Ltd Q1 2021 Earnings Call Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Vishal Biraia - Aviva Life Insurance Company India Ltd. - Analyst : Sir, my first question is on the overhead expenses. There has been a substantial reduction that we saw for this quarter. So what proportion of this is sustainable? Because this quarter, we saw -- I mean, there was no travel, there were no -- I mean, less overheads. So once things normalize, how would this pan out?

Question: Vishal Biraia - Aviva Life Insurance Company India Ltd. - Analyst : Okay. And sir, what would have been the key driving factors for the U.S. business because clearly, $47 million has been a relatively good number at a time when new launches have not been there. So have you been able to scale up those items in the U.S.? Or is it something else that is driving? Could you elaborate a bit on this?

Question: Vishal Biraia - Aviva Life Insurance Company India Ltd. - Analyst : Okay. Last question on Germany where you said the 97% of the issue should be resolved by September. So once things get back to normal, what would be the kind of growth that you foresee for the European market for FY '21?

Question: Nitin Agarwal - IDFC Securities Limited, Research Division - Analyst : So Sanjay, 2 things. One is, on the U.S., how has the shortage situations been in the U.S. over the last quarter, a couple of quarters? Have they sort of became more sporadic? Or do you see more opportunities there to participate in?

Question: Nitin Agarwal - IDFC Securities Limited, Research Division - Analyst : So we're not seeing any incremental opportunities on the participating shortages?

Question: Nitin Agarwal - IDFC Securities Limited, Research Division - Analyst : Okay. And on the pricing front, so does that mean there are relatively fewer price increase opportunities now to sort of take that further?

Question: Nitin Agarwal - IDFC Securities Limited, Research Division - Analyst : And then, sir, the last thing on sartans, since you've been a participant in the past, have you seen any meaningful price hikes in general across the portfolio? Or that's not really been the case because of the disruptions that are happening in the market?

Question: Nitin Agarwal - IDFC Securities Limited, Research Division - Analyst : No problem. And secondly, on the emerging markets, we had a very sharp growth this quarter. So anything to sort of how should we look at that? Is it like a sustainable base for the emerging markets? And any particular market which drove it? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. JULY 30, 2020 / 12:30PM, TORP.NS - Q1 2021 Torrent Pharmaceuticals Ltd Earnings Call

Question: Nitin Agarwal - IDFC Securities Limited, Research Division - Analyst : But Sudhir, was there any particular market which drove it or it was broad-based?

Question: Nitin Agarwal - IDFC Securities Limited, Research Division - Analyst : And last one, Sudhir, on the staff cost, is there an element of some sort of -- some reduction in staff cost or lower staff cost for the quarter because of -- due to this lower field -- lower promotion-related activities or there is -- that has just sort of entirely reflected only in the other expenses?

Question: Nitin Agarwal - IDFC Securities Limited, Research Division - Analyst : That is more a sustainable number, a regular number has been accounted for.

Question: Neha Manpuria - JPMorgan Chase & Co, Research Division - Analyst : My questions have been answered.

Question: Nitin Gosar - Invesco Asset Management (India) Private Limited - Analyst : Two questions. One is trying to understand COVID situation or post-COVID world, are companies in position to reassess the way they have been doing marketing and promotion for the product to the doctors? The whole idea is to understand, is there any lever to digitize the whole process and take it forward from here on? Lesser manpower involved. How do they see the situation from here on?

Question: Nitin Gosar - Invesco Asset Management (India) Private Limited - Analyst : Got it. One final question is with regard to currency. Do you think currency would have played a kind of its part in terms of gross margin expansion for the quarter?

Question: Nitin Gosar - Invesco Asset Management (India) Private Limited - Analyst : Okay. Got it. But on face of it, U.S. and other emerging market would have benefited and Brazil would have trended down.